Binimetinib is a targeted anti-cancer drug that works by blocking the MEK protein (a key protein that stimulates cancer cell growth) within cancer cells, thereby inhibiting tumor growth.
Authentic
Guarantee
Fast Delivery
Privacy Binimetinib, as an ATP-noncompetitive reversible MEK1/2 inhibitor, plays an important role in the treatment of unresectable or metastatic melanoma wit···【More】
Update: 24 Jun,2026Source: BigbearViews: 120
For many oncology patients facing prohibitively high targeted therapy costs, the Lao Dabang version of Binimetinib undoubtedly brings new hope—this ge···【More】
Update: 24 Jun,2026Source: BigbearViews: 114
BigBearPharma (Laos) has announced that its generic version of Binimetinib has officially received approval from the Lao Ministry of Health, under the···【More】
Update: 24 Jun,2026Source: BigbearViews: 113
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos